アレルゲン性が減少した免疫原性タンパク質加水分解物
本発明は、アレルゲン性が減少し、免疫原性が保持された新規ホエイタンパク質加水分解物に関する。新規ホエイタンパク質加水分解物は、少量のより大きなペプチドを有することも特徴とする。本発明はさらに、新規ホエイタンパク質加水分解物の調製法、新規ホエイタンパク質加水分解物の使用、及びこの新規ホエイタンパク質加水分解物を含む食品に関する。【選択図】 図２Ａ.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 25. März Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Japanisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-03-25, Last update posted on www.tib.eu: 2024-04-10, Last updated: 2024-04-19 |
|---|
| Patentnummer: |
JP2024513302 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003384942 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003384942 | ||
| 003 | DE-627 | ||
| 005 | 20240419120912.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240415s2024 xx |||||o 00| ||jpn c | ||
| 035 | |a (DE-627)EPA003384942 | ||
| 035 | |a (EPA)JP2024513302 | ||
| 035 | |a (EPA)80685419 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a jpn | ||
| 245 | 1 | 0 | |a アレルゲン性が減少した免疫原性タンパク質加水分解物 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-03-25, Last update posted on www.tib.eu: 2024-04-10, Last updated: 2024-04-19 | ||
| 520 | |a 本発明は、アレルゲン性が減少し、免疫原性が保持された新規ホエイタンパク質加水分解物に関する。新規ホエイタンパク質加水分解物は、少量のより大きなペプチドを有することも特徴とする。本発明はさらに、新規ホエイタンパク質加水分解物の調製法、新規ホエイタンパク質加水分解物の使用、及びこの新規ホエイタンパク質加水分解物を含む食品に関する。【選択図】 図２Ａ | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a C12P: Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture | |
| 650 | 4 | |a tec | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a A23L: Foods, foodstuffs, or non-alcoholic beverages, not covered by subclasses a21d or a23b-a23j; their preparation or treatment, e.g. cooking, modification of nutritive qualities, physical treatment (shaping or working, not fully covered by this subclass, a23p); preservation of foods or foodstuffs, in general | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 25. März |
| 773 | 1 | 8 | |g year:2024 |g day:25 |g month:03 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/80685419/publication/JP2024513302A1?q=JP2024513302 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 25 |c 03 | ||